flowbone SA
The company develops an injectable bioactive hydrogel platform designed for the targeted prevention of osteoporotic hip fractures. The gel is administered via a cannula into high-risk bone regions where it initiates the deposition of the body's own minerals to create strong, viable bone. The technology is intended for the 78 million people worldwide at high risk of hip fractures due to osteoporosis.
Visit websiteLausanne, Switzerland
Healthtech
Biotech
Medical Devices
Funding summary
- Total raised
- €1.2M
- Funding rounds
- 1
Investors in flowbone SA
Investors on record for flowbone SA. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like flowbone SA?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors